Shares of Synopsys, Inc. (NASDAQ:SNPS – Get Free Report) have received a consensus rating of “Hold” from the seventeen research firms that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, seven have given a hold recommendation and nine have given a buy recommendation to the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $563.8125.
A number of equities research analysts have issued reports on the company. Wells Fargo & Company increased their price target on Synopsys from $505.00 to $535.00 and gave the company an “equal weight” rating in a research report on Thursday. Morgan Stanley increased their price target on Synopsys from $480.00 to $525.00 and gave the company an “equal weight” rating in a research report on Thursday. Berenberg Bank set a $633.00 price target on Synopsys in a research report on Wednesday. KeyCorp reaffirmed an “overweight” rating on shares of Synopsys in a research report on Thursday. Finally, HSBC lowered Synopsys from a “buy” rating to a “hold” rating and set a $455.00 price target on the stock. in a research report on Friday, February 20th.
View Our Latest Stock Analysis on Synopsys
More Synopsys News
- Positive Sentiment: Synopsys said demand for AI chip design software is driving stronger business momentum, and it raised its annual forecast as a result. Synopsys raises annual forecast on demand for AI chip design software
- Positive Sentiment: The CFO highlighted that AI companies are increasingly using custom computer designs, a trend that could expand demand for Synopsys’ chip-design tools. AI Computer Design Diversity A Boon For Synopsys, Says CFO
- Positive Sentiment: Analysts raised price targets after the earnings report, signaling confidence in Synopsys’ longer-term growth outlook despite the stock’s recent weakness. Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Positive Sentiment: Synopsys also showcased new AI and multi-die design capabilities with Samsung Foundry, underscoring its role in advanced chip development. Synopsys Advances Power and Performance for AI and Multi-Die Designs on Latest Samsung Foundry Processes at SAFE Forum 2026
- Neutral Sentiment: The company beat fiscal Q2 estimates, with revenue up 41.9% year over year and EPS above expectations, but the market still sold the stock after the report. Synopsys Was the Worst S&P 500 Stock Thursday Despite Earnings Beat With AI and Merger in Focus
- Negative Sentiment: Investors appear wary about the company’s chip-IP business and the broader impact of integrating Ansys, which may be weighing on sentiment even after strong results. Synopsys slides even as Q2 results, guidance top estimates; adds activist to board
Institutional Investors Weigh In On Synopsys
Hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. raised its position in shares of Synopsys by 20.7% during the 3rd quarter. Vanguard Group Inc. now owns 18,181,185 shares of the semiconductor company’s stock worth $8,970,415,000 after acquiring an additional 3,120,401 shares in the last quarter. Victory Capital Management Inc. raised its position in shares of Synopsys by 238.8% during the 3rd quarter. Victory Capital Management Inc. now owns 2,824,349 shares of the semiconductor company’s stock worth $1,393,506,000 after acquiring an additional 1,990,608 shares in the last quarter. Coatue Management LLC acquired a new stake in shares of Synopsys during the 3rd quarter worth about $892,605,000. Capital Research Global Investors raised its position in shares of Synopsys by 226.6% during the 3rd quarter. Capital Research Global Investors now owns 2,524,512 shares of the semiconductor company’s stock worth $1,245,533,000 after acquiring an additional 1,751,432 shares in the last quarter. Finally, Norges Bank acquired a new stake in shares of Synopsys during the 4th quarter worth about $730,197,000. Institutional investors and hedge funds own 85.47% of the company’s stock.
Synopsys Stock Performance
Shares of Synopsys stock opened at $475.62 on Friday. The business has a 50-day moving average of $459.53 and a 200 day moving average of $454.45. Synopsys has a 12 month low of $376.18 and a 12 month high of $651.73. The stock has a market capitalization of $91.07 billion, a price-to-earnings ratio of 110.10, a price-to-earnings-growth ratio of 3.94 and a beta of 1.25. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.26.
Synopsys (NASDAQ:SNPS – Get Free Report) last posted its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. The company had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.Synopsys’s revenue for the quarter was up 41.9% compared to the same quarter last year. During the same quarter last year, the company earned $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, sell-side analysts forecast that Synopsys will post 10.28 earnings per share for the current year.
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
- Five stocks we like better than Synopsys
- Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
